Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |